- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,282GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,282GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,282GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,282GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,282GBP
- Report
- January 2022
- 200 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- March 2022
- 120 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- June 2021
- 120 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- August 2022
United States
From €1875EUR$1,940USD£1,612GBP
- Report
- August 2022
Global
From €764EUR$790USD£656GBP
- Report
- August 2021
Europe
From €3306EUR$3,420USD£2,842GBP
- Report
- August 2021
Global
From €3857EUR$3,990USD£3,315GBP
- Clinical Trials
- May 2020
- 323 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Drug Pipelines
- August 2020
- 206 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Report
- May 2022
- 40 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Drug Pipelines
- June 2021
- 221 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Report
- August 2022
- 385 Pages
Global
From €5577EUR$5,769USD£4,794GBP
- Report
- November 2023
- 200 Pages
Global
From €2706EUR$2,799USD£2,326GBP
Pruritus, or itching, is a common symptom of many skin conditions and can be treated with dermatological drugs. These drugs are typically divided into two categories: topical and systemic. Topical drugs are applied directly to the skin and can include corticosteroids, calcineurin inhibitors, and antihistamines. Systemic drugs are taken orally or injected and can include anticonvulsants, antidepressants, and opioids.
The pruritus drug market is a subset of the larger dermatological drug market. It is composed of a variety of drugs used to treat itching, including both topical and systemic treatments. These drugs are used to treat a wide range of skin conditions, from eczema and psoriasis to allergic reactions and insect bites.
Some companies in the pruritus drug market include Pfizer, Novartis, GlaxoSmithKline, Sanofi, and Merck. Show Less Read more